Evidence map›Paper›PMID 34926424›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Alberto Colella, Addolorata De Chiaro, Vincenzo Lettera

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alberto ColellaBiopox srl, Viale Maria Bakunin, Napoli, Italy.
Addolorata De ChiaroBiopox srl, Viale Maria Bakunin, Napoli, Italy.
Vincenzo LetteraBiopox srl, Viale Maria Bakunin, Napoli, Italy.
University of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present work was to develop an innovative and environmentally friendly process for wood fiber dyeing and to produce 3-dimensionally fully colored medium-density fiberboard (MDF). The potential of laccase-catalyzed polymerization of selected precursors to form dyes useful in fiberboard manufacturing, a technique used for the first time in this field, was demonstrated. Some of the 7 aromatic compounds tested yielded colored products after laccase treatment under both acid and alkaline conditions, and a good variety of colors was attained by using mixtures of two different monomers. To demonstrate the coloration and design potential of laccase conversion of aromatic compounds, MDFs were enzymatically dyed using an

Indexed as

colorsenzyme oxidationin situ dyeingmedium-density fiberboardPOXA1b

Identifiers

PMID34926424
PMCPMC8678495
OpenAlexW4200148716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.